BioAtla, Inc.
8-K
April 2, 2026
Key Highlights
- BioAtla is executing a 1-for-50 reverse stock split to maintain Nasdaq listing c...
- The move aims to boost share price above the $1.00 minimum requirement.
- The company maintains existing drug development partnerships, including with Bei...
Read Analysis
🤖 AI Generated